Does PMCF / PMS translation guarantee notified body acceptance or post-market evidence sufficiency?

No. Translation is one input into a broader post-market surveillance and conformity assessment process. AbroadLink delivers accurate PMCF and PMS translation, applies risk-based workflows, uses controlled medical device terminology, provides traceable certificates through CertLink and supports your QMS with documented processes. However, the manufacturer remains responsible for post-market surveillance, PMCF strategy, PMS adequacy, post-market evidence sufficiency, vigilance reporting, notified body communication and final compliance decisions. PMCF translation, PMS documentation translation and post-market surveillance translation are language-side contributions to your post-market system, not substitutes for clinical, regulatory, vigilance or product activities.